ICUI
ICU Medical, Inc.
Price Chart
Latest Quote
$142.95
+7.43 (+5.48%)
Current Price
| Previous Close | $135.52 |
| Open | $136.73 |
| Day High | $143.13 |
| Day Low | $136.68 |
| Volume | 311,804 |
Stock Information
| Shares Outstanding | 24.99M |
| Total Debt | $1.34B |
| Cash Equivalents | $292.68M |
| Revenue | $2.16B |
| Net Income | $46.34M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $3.57B |
| P/E Ratio | 76.85 |
| EPS (TTM) | $1.86 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.62B |
| Sales | $2.16B |
| Income | $46.34M |
| Book/sh | $84.50 |
| Cash/sh | $11.71 |
| Employees | 13K |
Financial Ratios
| Quick Ratio | 0.95 |
| Current Ratio | 2.34 |
| Debt/Eq | 63.62 |
Returns & Margins
| ROA | 1.68% |
| ROE | 2.26% |
| Gross Margin | 37.93% |
| Operating Margin | 5.73% |
| Profit Margin | 2.15% |
Ownership
| Insider Ownership | 3.80% |
| Institutional Ownership | 113.70% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 15.37 |
| PEG | 0.08 |
| P/S | 1.66 |
| P/B | 1.69 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $172.50 |
Technical Indicators
| SMA20 | $138.01 |
| SMA50 | $129.90 |
| SMA200 | $135.06 |
| RSI | 65.79 |
| ATR | 4.8029 |
| Shares Float | 24.51M |
| Short Float | 8.81% |
| Short Ratio | 5.92 |
| Volatility | 0.78 |
| Rel Volume | 1.10 |
Performance History
| Week | +0.38% |
| Month | +7.23% |
| Quarter | +10.47% |
| 6 Months | -1.52% |
| YTD | +3.19% |
| Year | +11.62% |
| 3 Years | -24.34% |
| 5 Years | -30.21% |
| 10 Years | +36.09% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $142.95 | 322,700 |
| 2026-06-23 | $135.52 | 232,300 |
| 2026-06-22 | $136.14 | 339,800 |
| 2026-06-18 | $140.37 | 506,700 |
| 2026-06-17 | $137.94 | 245,300 |
| 2026-06-16 | $142.41 | 235,400 |
| 2026-06-15 | $143.72 | 195,900 |
| 2026-06-12 | $142.20 | 265,500 |
| 2026-06-11 | $142.86 | 237,400 |
| 2026-06-10 | $139.83 | 240,200 |
| 2026-06-09 | $142.00 | 274,600 |
| 2026-06-08 | $137.48 | 296,700 |
| 2026-06-05 | $136.61 | 274,600 |
| 2026-06-04 | $134.93 | 275,100 |
| 2026-06-03 | $130.52 | 224,600 |
| 2026-06-02 | $130.48 | 292,800 |
| 2026-06-01 | $131.64 | 307,300 |
| 2026-05-29 | $135.39 | 296,500 |
| 2026-05-28 | $138.87 | 489,800 |
| 2026-05-27 | $138.34 | 325,500 |
| 2026-05-26 | $134.97 | 420,700 |
About ICU Medical, Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
đ° Latest News
ICUI or MDLN: Which Is the Better Value Stock Right Now?
Zacks âĸ 2026-06-18T15:40:03Z
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
StockStory âĸ 2026-06-16T14:49:04Z
ICU Medical (ICUI) Stock Valuation Check After Recent Momentum And Discount To Estimated Fair Value
Simply Wall St. âĸ 2026-06-14T21:09:42Z
ICU Medical (ICUI) Strengthens Amid Competitorsâ Quality Issues
Insider Monkey âĸ 2026-06-12T15:34:52Z
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
StockStory âĸ 2026-06-12T11:33:20Z
ICU Medical's General Counsel Sells â The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells â The Smiths Integration Is still playing out.
Motley Fool âĸ 2026-06-10T23:56:01Z
2 Small-Cap Stocks with Solid Fundamentals and 1 Facing Headwinds
StockStory âĸ 2026-05-22T22:04:55Z
ICU Medical (ICUI) Valuation Check After Earnings Beat And Reaffirmed Profit Guidance
Simply Wall St. âĸ 2026-05-20T03:15:26Z
5 Must-Read Analyst Questions From ICU Medicalâs Q1 Earnings Call
StockStory âĸ 2026-05-17T16:36:55Z
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
StockStory âĸ 2026-05-13T21:00:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,409,223,000 | $1,557,264,000 | $1,519,253,000 | $1,582,236,000 |
| Cost Of Revenue | $1,409,223,000 | $1,557,264,000 | $1,519,253,000 | $1,582,236,000 |
| Total Revenue | $2,231,262,000 | $2,382,046,000 | $2,259,126,000 | $2,279,997,000 |
| Operating Revenue | $2,231,262,000 | $2,382,046,000 | $2,259,126,000 | $2,279,997,000 |
| Expenses | ||||
| Interest Expense | $93,338,000 | $106,541,000 | $102,727,000 | $70,805,000 |
| Total Expenses | $2,121,928,000 | $2,284,641,000 | $2,211,290,000 | $2,283,565,000 |
| Other Income Expense | $-21,945,000 | $-67,664,000 | $-30,916,000 | $-44,466,000 |
| Other Non Operating Income Expenses | $348,000 | $-1,823,000 | $166,000 | $3,198,000 |
| Net Non Operating Interest Income Expense | $-83,031,000 | $-95,753,000 | $-95,219,000 | $-66,375,000 |
| Interest Expense Non Operating | $93,338,000 | $106,541,000 | $102,727,000 | $70,805,000 |
| Operating Expense | $712,705,000 | $727,377,000 | $692,037,000 | $701,329,000 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Net Interest Income | $-83,031,000 | $-95,753,000 | $-95,219,000 | $-66,375,000 |
| Interest Income | $10,307,000 | $10,788,000 | $7,508,000 | $4,430,000 |
| Normalized Income | $18,343,470 | $-65,673,610 | $-5,100,220 | $-43,352,064 |
| Net Income From Continuing And Discontinued Operation | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Total Operating Income As Reported | $42,829,000 | $42,964,000 | $22,825,000 | $-42,898,000 |
| Net Income Common Stockholders | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Net Income | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Net Income Including Noncontrolling Interests | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Net Income Continuous Operations | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Earnings From Equity Interest Net Of Tax | $-1,189,000 | $0 | $0 | - |
| Pretax Income | $4,358,000 | $-66,012,000 | $-78,299,000 | $-114,409,000 |
| Special Income Charges | $-26,079,000 | $-56,049,000 | $-25,164,000 | $-41,884,000 |
| Interest Income Non Operating | $10,307,000 | $10,788,000 | $7,508,000 | $4,430,000 |
| Operating Income | $109,334,000 | $97,405,000 | $47,836,000 | $-3,568,000 |
| Gross Profit | $822,039,000 | $824,782,000 | $739,873,000 | $697,761,000 |
| Per Share | ||||
| Diluted EPS | $0.03 | $-4.83 | $-1.23 | $-3.11 |
| Basic EPS | $0.03 | $-4.83 | $-1.23 | $-3.11 |
| Other | ||||
| Tax Effect Of Unusual Items | $-4,681,530 | $-13,826,610 | $-6,527,220 | $-16,730,064 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $320,730,000 | $325,882,000 | $284,284,000 | $239,211,000 |
| Total Unusual Items | $-22,293,000 | $-65,841,000 | $-31,082,000 | $-47,664,000 |
| Total Unusual Items Excluding Goodwill | $-22,293,000 | $-65,841,000 | $-31,082,000 | $-47,664,000 |
| Reconciled Depreciation | $200,741,000 | $219,512,000 | $228,774,000 | $235,151,000 |
| EBITDA (Bullshit earnings) | $298,437,000 | $260,041,000 | $253,202,000 | $191,547,000 |
| EBIT | $97,696,000 | $40,529,000 | $24,428,000 | $-43,604,000 |
| Diluted Average Shares | $24,904,000 | $24,388,000 | $24,091,000 | $23,868,000 |
| Basic Average Shares | $24,640,000 | $24,388,000 | $24,091,000 | $23,868,000 |
| Diluted NI Availto Com Stockholders | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Tax Provision | $2,437,000 | $51,676,000 | $-48,644,000 | $-40,123,000 |
| Gain On Sale Of Ppe | $-4,366,000 | $-1,608,000 | $-153,000 | $-2,554,000 |
| Gain On Sale Of Business | $44,792,000 | $0 | $0 | - |
| Restructuring And Mergern Acquisition | $66,505,000 | $54,441,000 | $25,011,000 | $39,330,000 |
| Gain On Sale Of Security | $3,786,000 | $-9,792,000 | $-5,918,000 | $-5,780,000 |
| Research And Development | $87,495,000 | $88,615,000 | $85,344,000 | $92,984,000 |
| Selling General And Administration | $625,210,000 | $638,762,000 | $606,693,000 | $608,345,000 |
Fetched: 2026-06-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-9,488,000 | $-208,326,000 | $-219,624,000 | $-342,096,000 |
| Total Assets | $4,050,508,000 | $4,203,931,000 | $4,378,439,000 | $4,515,641,000 |
| Total Non Current Assets | $2,859,954,000 | $2,761,948,000 | $3,157,167,000 | $3,280,445,000 |
| Other Non Current Assets | $53,463,000 | $50,800,000 | $49,251,000 | $40,691,000 |
| Non Current Deferred Assets | $25,891,000 | $24,211,000 | $40,734,000 | $36,622,000 |
| Non Current Deferred Taxes Assets | $25,891,000 | $24,211,000 | $37,295,000 | $31,466,000 |
| Financial Assets | $3,815,000 | $11,038,000 | $4,876,000 | $26,753,000 |
| Goodwill And Other Intangible Assets | $2,133,313,000 | $2,173,561,000 | $2,343,034,000 | $2,432,024,000 |
| Other Intangible Assets | $633,559,000 | $740,789,000 | $870,588,000 | $982,766,000 |
| Current Assets | $1,190,554,000 | $1,441,983,000 | $1,221,272,000 | $1,235,196,000 |
| Other Current Assets | $20,500,000 | $22,593,000 | $3,667,000 | $3,532,000 |
| Hedging Assets Current | $3,745,000 | $11,038,000 | $29,850,000 | $33,291,000 |
| Assets Held For Sale Current | $0 | $284,382,000 | $0 | - |
| Current Deferred Assets | $13,110,000 | $9,060,000 | $7,490,000 | $6,225,000 |
| Prepaid Assets | $25,472,000 | $21,528,000 | $34,035,000 | $36,231,000 |
| Inventory | $615,859,000 | $584,676,000 | $709,360,000 | $696,009,000 |
| Receivables | $203,905,000 | $200,140,000 | $182,147,000 | $246,900,000 |
| Other Receivables | $23,390,000 | $17,312,000 | $17,833,000 | $21,635,000 |
| Accounts Receivable | $180,515,000 | $182,828,000 | $161,566,000 | $221,719,000 |
| Allowance For Doubtful Accounts Receivable | $-14,383,000 | $-12,977,000 | $-11,064,000 | $-8,530,000 |
| Gross Accounts Receivable | $194,898,000 | $195,805,000 | $172,630,000 | $230,249,000 |
| Cash Cash Equivalents And Short Term Investments | $307,963,000 | $308,566,000 | $254,723,000 | $213,008,000 |
| Cash And Cash Equivalents | $307,963,000 | $308,566,000 | $254,222,000 | $208,784,000 |
| Non Current Accounts Receivable | - | $23,631,000 | $30,627,000 | $27,086,000 |
| Current Deferred Taxes Assets | - | $5,511,000 | $5,822,000 | $3,830,000 |
| Taxes Receivable | - | $4,445,000 | $2,748,000 | $3,546,000 |
| Investmentin Financial Assets | - | - | $0 | $516,000 |
| Debt | ||||
| Net Debt | $976,704,000 | $1,274,292,000 | $1,374,548,000 | $1,444,579,000 |
| Total Debt | $1,332,347,000 | $1,625,967,000 | $1,703,857,000 | $1,734,303,000 |
| Long Term Debt And Capital Lease Obligation | $1,313,597,000 | $1,574,967,000 | $1,632,696,000 | $1,686,446,000 |
| Long Term Debt | $1,265,917,000 | $1,531,858,000 | $1,577,770,000 | $1,623,675,000 |
| Current Debt And Capital Lease Obligation | $18,750,000 | $51,000,000 | $71,161,000 | $47,857,000 |
| Current Debt | $18,750,000 | $51,000,000 | $51,000,000 | $29,688,000 |
| Other Current Borrowings | $18,750,000 | $51,000,000 | $51,000,000 | $29,688,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,926,683,000 | $2,238,696,000 | $2,255,029,000 | $2,425,713,000 |
| Total Non Current Liabilities Net Minority Interest | $1,427,822,000 | $1,682,514,000 | $1,773,191,000 | $1,931,154,000 |
| Other Non Current Liabilities | $41,856,000 | $23,636,000 | $33,929,000 | $54,355,000 |
| Tradeand Other Payables Non Current | $34,613,000 | $35,097,000 | $35,060,000 | $41,796,000 |
| Non Current Deferred Liabilities | $37,756,000 | $48,814,000 | $66,458,000 | $142,246,000 |
| Non Current Deferred Taxes Liabilities | $37,756,000 | $48,814,000 | $55,873,000 | $126,007,000 |
| Current Liabilities | $498,861,000 | $556,182,000 | $481,838,000 | $494,559,000 |
| Current Deferred Liabilities | $33,843,000 | $30,358,000 | $31,640,000 | $30,838,000 |
| Payables And Accrued Expenses | $360,872,000 | $358,531,000 | $307,825,000 | $372,935,000 |
| Payables | $164,774,000 | $165,348,000 | $167,516,000 | $233,740,000 |
| Total Tax Payable | $10,400,000 | $17,328,000 | $17,486,000 | $17,838,000 |
| Income Tax Payable | $10,400,000 | $17,328,000 | $7,714,000 | $6,200,000 |
| Accounts Payable | $154,374,000 | $148,020,000 | $150,030,000 | $215,902,000 |
| Other Current Liabilities | - | $32,911,000 | $7,469,000 | $1,847,000 |
| Interest Payable | - | $667,000 | $1,431,000 | $1,033,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $2,123,825,000 | $1,965,235,000 | $2,123,410,000 | $2,089,928,000 |
| Total Equity Gross Minority Interest | $2,123,825,000 | $1,965,235,000 | $2,123,410,000 | $2,089,928,000 |
| Stockholders Equity | $2,123,825,000 | $1,965,235,000 | $2,123,410,000 | $2,089,928,000 |
| Gains Losses Not Affecting Retained Earnings | $-34,630,000 | $-139,401,000 | $-53,081,000 | $-80,978,000 |
| Other Equity Adjustments | $-34,630,000 | $-139,401,000 | $-53,081,000 | $-80,978,000 |
| Retained Earnings | $690,890,000 | $690,158,000 | $807,846,000 | $837,501,000 |
| Long Term Equity Investment | $131,586,000 | $3,038,000 | $3,120,000 | $3,178,000 |
| Other | ||||
| Treasury Shares Number | $172 | $571 | $2,428 | $1,633 |
| Ordinary Shares Number | $24,688,000 | $24,517,000 | $24,141,000 | $23,993,000 |
| Share Issued | $24,688,172 | $24,517,571 | $24,143,428 | $23,994,633 |
| Tangible Book Value | $-9,488,000 | $-208,326,000 | $-219,624,000 | $-342,096,000 |
| Invested Capital | $3,408,492,000 | $3,548,093,000 | $3,752,180,000 | $3,743,291,000 |
| Working Capital | $691,693,000 | $885,801,000 | $739,434,000 | $740,637,000 |
| Capital Lease Obligations | $47,680,000 | $43,109,000 | $75,087,000 | $80,940,000 |
| Total Capitalization | $3,389,742,000 | $3,497,093,000 | $3,701,180,000 | $3,713,603,000 |
| Treasury Stock | $22,000 | $92,000 | $262,000 | $243,000 |
| Additional Paid In Capital | $1,465,118,000 | $1,412,118,000 | $1,366,493,000 | $1,331,249,000 |
| Capital Stock | $2,469,000 | $2,452,000 | $2,414,000 | $2,399,000 |
| Common Stock | $2,469,000 | $2,452,000 | $2,414,000 | $2,399,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $47,680,000 | $43,109,000 | $54,926,000 | $62,771,000 |
| Current Deferred Revenue | $33,843,000 | $30,358,000 | $31,640,000 | $30,838,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $60,799,000 | $59,445,000 | $40,567,000 | $33,182,000 |
| Current Provisions | $24,597,000 | $23,937,000 | $23,176,000 | $7,900,000 |
| Current Accrued Expenses | $196,098,000 | $193,183,000 | $140,309,000 | $139,195,000 |
| Investments And Advances | $131,586,000 | $3,038,000 | $3,120,000 | $3,694,000 |
| Investmentsin Associatesat Cost | $131,586,000 | $3,038,000 | - | - |
| Goodwill | $1,499,754,000 | $1,432,772,000 | $1,472,446,000 | $1,449,258,000 |
| Net PPE | $511,886,000 | $499,300,000 | $685,525,000 | $713,575,000 |
| Accumulated Depreciation | $-645,913,000 | $-592,897,000 | $-623,888,000 | $-526,444,000 |
| Gross PPE | $1,157,799,000 | $1,092,197,000 | $1,309,413,000 | $1,240,019,000 |
| Construction In Progress | $90,748,000 | $87,006,000 | $117,219,000 | $152,909,000 |
| Other Properties | $315,806,000 | $277,162,000 | $277,861,000 | $253,146,000 |
| Machinery Furniture Equipment | $574,273,000 | $550,940,000 | $636,082,000 | $559,901,000 |
| Properties | $176,972,000 | $177,089,000 | $278,251,000 | $274,063,000 |
| Finished Goods | $312,379,000 | $281,873,000 | $354,417,000 | $335,250,000 |
| Work In Process | $38,097,000 | $37,528,000 | $58,906,000 | $73,795,000 |
| Raw Materials | $265,383,000 | $265,275,000 | $296,037,000 | $286,964,000 |
| Employee Benefits | - | $3,830,000 | $4,207,000 | $5,314,000 |
| Non Current Accrued Expenses | - | $618,000 | $841,000 | $997,000 |
| Non Current Deferred Revenue | - | $9,045,000 | $10,585,000 | $16,239,000 |
| Current Capital Lease Obligation | - | $15,695,000 | $20,161,000 | $18,169,000 |
| Other Short Term Investments | - | $0 | $501,000 | $4,224,000 |
| Available For Sale Securities | - | - | - | $516,000 |
Fetched: 2026-06-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $82,832,000 | $113,827,000 | $72,531,000 | $-161,458,000 |
| Operating Activities | ||||
| Operating Cash Flow | $179,847,000 | $204,033,000 | $166,201,000 | $-62,129,000 |
| Cash Flow From Continuing Operating Activities | $179,847,000 | $204,033,000 | $166,201,000 | $-62,129,000 |
| Operating Gains Losses | $-35,240,000 | $2,522,000 | $2,109,000 | $2,010,000 |
| Investing Activities | ||||
| Capital Expenditure | $-97,015,000 | $-90,206,000 | $-93,670,000 | $-99,329,000 |
| Investing Cash Flow | $122,229,000 | $-88,960,000 | $-87,947,000 | $-1,909,468,000 |
| Cash Flow From Continuing Investing Activities | $122,229,000 | $-88,960,000 | $-87,947,000 | $-1,909,468,000 |
| Net Other Investing Changes | $8,059,000 | $746,000 | $1,501,000 | $989,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-311,525,000 | $-55,800,000 | $-35,979,000 | $1,637,032,000 |
| Cash Flow From Continuing Financing Activities | $-311,525,000 | $-55,800,000 | $-35,979,000 | $1,637,032,000 |
| Net Other Financing Charges | $-13,146,000 | $-14,592,000 | $-9,350,000 | $-13,060,000 |
| Other | ||||
| Repayment Of Debt | $-304,798,000 | $-52,147,000 | $-30,651,000 | $-23,055,000 |
| Issuance Of Debt | $313,000 | $0 | $0 | $1,664,362,000 |
| Interest Paid Supplemental Data | $83,742,000 | $99,717,000 | $95,913,000 | $63,713,000 |
| End Cash Position | $307,963,000 | $308,566,000 | $254,222,000 | $208,784,000 |
| Beginning Cash Position | $308,566,000 | $254,222,000 | $208,784,000 | $552,827,000 |
| Effect Of Exchange Rate Changes | $8,846,000 | $-4,929,000 | $3,163,000 | $-9,478,000 |
| Changes In Cash | $-9,449,000 | $59,273,000 | $42,275,000 | $-334,565,000 |
| Proceeds From Stock Option Exercised | $6,106,000 | $10,939,000 | $4,022,000 | $8,785,000 |
| Net Issuance Payments Of Debt | $-304,485,000 | $-52,147,000 | $-30,651,000 | $1,641,307,000 |
| Net Long Term Debt Issuance | $-304,485,000 | $-52,147,000 | $-30,651,000 | $1,641,307,000 |
| Long Term Debt Payments | $-304,798,000 | $-52,147,000 | $-30,651,000 | $-23,055,000 |
| Long Term Debt Issuance | $313,000 | $0 | $0 | $1,664,362,000 |
| Net Investment Purchase And Sale | $0 | $500,000 | $4,222,000 | $33,036,000 |
| Sale Of Investment | $0 | $500,000 | $4,222,000 | $36,433,000 |
| Net Business Purchase And Sale | $211,185,000 | $0 | $0 | $-1,844,164,000 |
| Sale Of Business | $211,185,000 | $0 | $0 | - |
| Net Intangibles Purchase And Sale | $-8,972,000 | $-10,833,000 | $-9,777,000 | $-9,018,000 |
| Purchase Of Intangibles | $-8,972,000 | $-10,833,000 | $-9,777,000 | $-9,018,000 |
| Net PPE Purchase And Sale | $-88,043,000 | $-79,373,000 | $-83,893,000 | $-90,311,000 |
| Purchase Of PPE | $-88,043,000 | $-79,373,000 | $-83,893,000 | $-90,311,000 |
| Change In Working Capital | $-90,044,000 | $-2,569,000 | $-135,603,000 | $-303,729,000 |
| Change In Other Working Capital | $-24,759,000 | $26,230,000 | $-82,356,000 | $-66,734,000 |
| Change In Other Current Assets | $-6,982,000 | $-23,154,000 | $-24,695,000 | $-21,290,000 |
| Change In Payables And Accrued Expense | $-29,969,000 | $33,199,000 | $-82,780,000 | $-18,362,000 |
| Change In Accrued Expense | $-36,967,000 | $20,668,000 | $-14,479,000 | $-55,834,000 |
| Change In Payable | $6,998,000 | $12,531,000 | $-68,301,000 | $37,472,000 |
| Change In Account Payable | $6,998,000 | $12,531,000 | $-68,301,000 | $37,472,000 |
| Change In Prepaid Assets | $-10,958,000 | $-8,829,000 | $11,672,000 | $22,903,000 |
| Change In Inventory | $-26,252,000 | $16,829,000 | $-6,079,000 | $-201,095,000 |
| Change In Receivables | $8,876,000 | $-46,844,000 | $48,635,000 | $-19,151,000 |
| Changes In Account Receivables | $8,876,000 | $-46,844,000 | $48,635,000 | $-19,151,000 |
| Other Non Cash Items | $47,900,000 | $55,373,000 | $60,013,000 | $36,762,000 |
| Stock Based Compensation | $55,758,000 | $46,883,000 | $40,563,000 | $36,025,000 |
| Depreciation Amortization Depletion | $200,741,000 | $219,512,000 | $228,774,000 | $235,151,000 |
| Depreciation And Amortization | $200,741,000 | $219,512,000 | $228,774,000 | $235,151,000 |
| Earnings Losses From Equity Investments | $1,189,000 | $0 | $0 | - |
| Gain Loss On Sale Of PPE | $5,900,000 | $2,522,000 | $2,109,000 | $2,010,000 |
| Gain Loss On Sale Of Business | $-44,792,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $732,000 | $-117,688,000 | $-29,655,000 | $-74,286,000 |
| Income Tax Paid Supplemental Data | - | $25,253,000 | $35,809,000 | $27,504,000 |
| Purchase Of Investment | - | $0 | $0 | $-3,397,000 |
| Purchase Of Business | - | $0 | $0 | $-1,844,164,000 |
| Provisionand Write Offof Assets | - | $6,930,000 | $22,420,000 | $5,938,000 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-24